公開日期 | 標題 | 作者 | 來源出版物 | WOS | 全文 |
2011 | Efficient and reliable skin responses with unconventional low-dose total skin electron beam therapy in mycosis fungoides: A phase II study | Harrison, C.; Navi, D.; Lingala, B.; Armstrong, R.; Weng, W.; Sundram, U.; Dabaja, B.; Singh, L.; Duvic, M.; Hoppe, R. T.; Kim, Y. H. | Journal of Investigative Dermatology | | |
2012 | Graft-versus-lymphoma effect after non-myeloablative allogeneic transplant induces molecular remission assessed by high-throughput sequencing of T cell receptor in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Journal of Investigative Dermatology | | |
2011 | Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Blood | | |
2014 | Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sezary Syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Benjamin, J. E.; Negrin, R. S.; Reddy, S.; Million, L.; Hoppe, R. T.; Kim, Y. H. | Blood | | |
2020 | Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma | Wen-Kai Weng ; Arai, S.; Rezvani, A.; Johnston, L.; Lowsky, R.; Miklos, D.; Shizuru, J.; Muffly, L.; Meyer, E.; Negrin, R. S.; Wang, E.; Almazan, T.; Million, L.; Khodadoust, M.; Li, S. F.; Hoppe, R. T.; Kim, Y. H. | Blood Advances | | |
2018 | Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort | Spinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Elder, L. V.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R. | Blood | | |
2019 | Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort | Spinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R. | Blood Advances | | |
2014 | Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience | Wudhikarn, K.; Lavori, P.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Hoppe, R. T.; Benjamin, J.; Meyer, E.; Negrin, R.; Wen-Kai Weng | Biology of Blood and Marrow Transplantation | | |
2015 | Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project | Kim, Y. H.; Tavallaee, M.; Sundram, U.; Salva, K. A.; Wood, G. S.; Li, S. F.; Rozati, S.; Nagpal, S.; Krathen, M.; Reddy, S.; Hoppe, R. T.; Nguyen-Lin, A.; Wen-Kai Weng ; Armstrong, R.; Pulitzer, M.; Advani, R. H.; Horwitz, S. M. | Journal of Clinical Oncology | | |
2016 | A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT) | Kim, Y. H.; Hoppe, R. T.; Rook, A. H.; Maity, A.; Geskin, L. J.; Horowitz, D. P.; Finnegan, G.; Khodadoust, M.; Wen-Kai Weng ; Lares, A.; Hong, E. K. J.; Buchanan, M.; Ma, V.; Kha, H.; Lawrence, C. E.; Vainstein, V.; Basile, L. A. | Blood | | |
2009 | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors | Kohrt, H. E.; Turnbull, B. B.; Heydari, K.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Hoppe, R. T.; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | | |
2014 | Use of High-Throughput Sequencing (HTS) of TCR beta to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Hoppe, R. T.; Meyer, E. H.; Kim, Y. H. | Blood | | |
2019 | Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs | Obeid, J. P.; Gutkin, P. M.; Lewis, J.; Skinner, L.; Wang, E. B.; Khodadoust, M. S.; Kim, Y. H.; Wen-Kai Weng ; Hoppe, R. T.; Hiniker, S. M. | Practical Radiation Oncology | | |